Absorption, Disposition, and Metabolism of Rosiglitazone, a Potent Thiazolidinedione Insulin Sensitizer, in Humans
- 1 July 2000
- journal article
- clinical trial
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 28 (7) , 772-780
- https://doi.org/10.1016/s0090-9556(24)15347-0
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Expression of Putative Fatty Acid Transporter Genes Are Regulated by Peroxisome Proliferator-activated Receptor α and γ Activators in a Tissue- and Inducer-specific MannerJournal of Biological Chemistry, 1998
- Identification of High-Affinity Binding Sites for the Insulin Sensitizer Rosiglitazone (BRL-49653) in Rodent and Human Adipocytes Using a Radioiodinated Ligand for Peroxisomal Proliferator-Activated Receptor γThe Journal of Pharmacology and Experimental Therapeutics, 1998
- Coordinate Regulation of the Expression of the Fatty Acid Transport Protein and Acyl-CoA Synthetase Genes by PPARα and PPARγ ActivatorsJournal of Biological Chemistry, 1997
- THIAZOLIDINEDIONESEndocrinology and Metabolism Clinics of North America, 1997
- The Thiazolidinedione Insulin Sensitiser, BRL 49653, Increases the Expression of PPAR-γ and aP2in Adipose Tissue of High-Fat-Fed RatsBiochemical and Biophysical Research Communications, 1996
- Activation of the Nuclear Receptor Peroxisome Proliferator-activated Receptor γ Promotes Brown Adipocyte DifferentiationJournal of Biological Chemistry, 1996
- PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene.The EMBO Journal, 1996
- The Structure−Activity Relationship between Peroxisome Proliferator-Activated Receptor γ Agonism and the Antihyperglycemic Activity of ThiazolidinedionesJournal of Medicinal Chemistry, 1996
- An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)Journal of Biological Chemistry, 1995
- Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curveJournal of Pharmacokinetics and Biopharmaceutics, 1978